PEOPLE - Changes at Vivacta:
This article was originally published in Clinica
Executive Summary
In vitro diagnostics firm Vivacta has appointed Rolf Classon as chairman and Werner Schafer as non-executive director. Mr Classon joins the Kent, UK firm from Bayer Healthcare, where he was chairman of the executive committee. Dr Schafer joins Vivacta from Lab Systems Business Unit, Roche, where he was president.